Literature DB >> 7568910

The S-100: a protein family in search of a function.

G Fanò1, S Biocca, S Fulle, M A Mariggiò, S Belia, P Calissano.   

Abstract

The S-100 is a group of low molecular weight (10-12 kD) calcium-binding proteins highly conserved among vertebrates. It is present in different tissues as dimers of homologous or different subunits (alpha, beta). In the nervous system, the S-100 exists as a mixture composed of beta beta and alpha beta dimers with the monomer beta represented more often. Its intracellular localisation is mainly restricted to the glial cytoplasmic compartment with a small fraction bound to membranes. In this compartment the S-100 acts as a potent inhibitor of phosphorylation on several substrates including the synaptosomal C-Kinase and Tau, a microtubule-associated protein. The S-100 in particular conditions, after binding with specific membrane sites (Kd = 0.2 microM; Bmax = 4.5 nM), is able to modify the activity of adenylate cyclase, probably via G-proteins. In addition, the Ca2+ homeostasis is also modulated by S-100 via an increase of specific membrane conductance and/or Ca2+ release from intracellular stores. "In vitro" and "in vivo" experiments showed that lower (nM) concentrations of extracellular S-100 beta act on glial and neuronal cells as a growth-differentiating factor. On the other hand, higher concentrations of the protein induce apoptosis of some cells such as the sympathetic-like PC12 line. Finally, data obtained from physiological (development, ageing) or pathological (dementia associated with Down's syndrome, Alzheimer's disease) conditions showed that a relationship could be established between the S-100 levels and some aspects of the statii.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568910     DOI: 10.1016/0301-0082(94)00062-m

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  41 in total

Review 1.  [Neuromonitoring with S-100 protein in the intensive care unit].

Authors:  M Fries; J Bickenbach; S Beckers; D Henzler; R Rossaint; R Kuhlen
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

2.  Variations in immunohistochemical preservation of proteins in a mummification model.

Authors:  Ryan Metcalfe; Tony Freemont
Journal:  J Anat       Date:  2011-11-04       Impact factor: 2.610

3.  Comparative proteome analysis for identification of differentially abundant proteins in SIDS.

Authors:  Noha El-Kashef; Iva Gomes; Katja Mercer-Chalmers-Bender; Peter M Schneider; Markus A Rothschild; Martin Juebner
Journal:  Int J Legal Med       Date:  2017-07-17       Impact factor: 2.686

4.  S100beta protein expression: gender- and age-related daily changes.

Authors:  M I Nogueira; S Y Abbas; L G M Campos; W Allemandi; P Lawson; S H Takada; E C Azmitia
Journal:  Neurochem Res       Date:  2009-02-11       Impact factor: 3.996

5.  Antiserum against S-100 protein prevents long term potentiation through a cAMP-related mechanism.

Authors:  R Rebaudo; R Melani; M Balestrino; A Cupello; K Haglid; H Hydèn
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

6.  Modulation of quaternary structure of S100 proteins by calcium ions.

Authors:  Werner W Streicher; Maria M Lopez; George I Makhatadze
Journal:  Biophys Chem       Date:  2010-06-23       Impact factor: 2.352

Review 7.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

8.  Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding.

Authors:  M J Raftery; C A Harrison; P Alewood; A Jones; C L Geczy
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model.

Authors:  Lee A Shapiro; Lynn A Bialowas-McGoey; Patricia M Whitaker-Azmitia
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-22

10.  Perinatal S100B Protein Assessment in Human Unconventional Biological Fluids: A Minireview and New Perspectives.

Authors:  Diego Gazzolo; Fabrizio Michetti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.